Call for Abstract

8th Global Meeting on Oncology and Radiology, will be organized around the theme “”

RADIOLOGY AND ONCOLOGY 2024 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in RADIOLOGY AND ONCOLOGY 2024

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Imaging technology in the context of radiology and oncology refers to the use of various techniques and equipment to visualize the internal structures of the human body, aiding in disease diagnosis, treatment planning, and monitoring. It encompasses a spectrum of modalities such as X-rays, CT scans, MRI, ultrasound, and nuclear medicine, each offering unique insights into tissues and organs. Artificial intelligence is accelerating image analysis, automating routine tasks, and uncovering subtle abnormalities in radiological scans, leading to early cancer detection and improved treatment decisions. The integration of multiple imaging modalities, such as PET-CT, offers comprehensive views of cancerous lesions, aiding in precise tumor staging and monitoring.

Artificial Intelligence (AI) has emerged as a game-changer in the fields of radiology and oncology, reshaping the way medical professionals diagnose and treat patients. The integration of AI technology holds the promise of significantly enhancing the precision, speed, and efficiency of healthcare practices in these critical domains. AI algorithms are increasingly automating the analysis of radiological images, rapidly and accurately identifying anomalies, even the most subtle ones, in X-rays, MRIs, and CT scans.

Radiation therapy is a critical component of oncology, playing a pivotal role in the comprehensive treatment of cancer. This technique utilizes high-energy radiation to target and destroy cancer cells while sparing surrounding healthy tissue. In the context of a radiology and oncology conference, it's essential to provide an introductory overview of this field and its latest innovations.

Recent advances in radiology and oncology have ushered in transformative methods for early cancer detectionLiquid biopsies, cutting-edge imaging techniques, and AI-powered genomic screening enhance the precision of cancer identification and personalized interventions, offering new hope for improved patient outcomes. These innovations take the spotlight at radiology and oncology conferences, shaping the future of cancer care.

Multidisciplinary cancer care refers to a comprehensive approach to cancer treatment that involves collaboration among various medical professionals from different specialties. This team-based approach typically includes oncologists, surgeons, radiologists, pathologists, nurses, and other specialists, all working together to provide the most effective and personalized care for cancer patients. Multidisciplinary cancer care aims to improve treatment outcomes, enhance patient quality of life, and ensure that each patient receives the best available treatments and support throughout their cancer journey.

  • Precision Medicine
  • Imaging Integration
  • Immunotherapy and Targeted Therapies
  • Minimally Invasive Procedures
  • Supportive Care

Precision medicine, also known as personalized medicine in oncology represents a revolutionary approach, tailoring cancer treatments to an individual's genetic profile. Recent innovations involve the use of advanced molecular diagnostics and genomics, enabling oncologists to identify specific mutations and biomarkers. These findings guide the selection of targeted therapies, immunotherapies, and treatment strategies, delivering more effective and personalized care.

  • Advanced Molecular Diagnostics
  • Genomic Profiling
  • Targeted Therapies
  • Immunotherapy

Radiogenomics, at the nexus of radiology and genomics, is an emerging field that investigates the genetic basis of an individual's response to radiation therapy. Recent innovations in radiogenomics have revealed how genetic variations influence a patient's tolerance and response to radiation, allowing for personalized treatment plans. At radiology and oncology conferences, radiogenomics takes center stage, highlighting cutting-edge research and its potential to improve the precision and efficacy of radiation therapy, ultimately enhancing patient outcomes.

Interventional radiology, a vital subspecialty in the fields of radiology and oncology, involves minimally invasive procedures guided by medical imaging. Recent innovations have expanded the role of interventional radiology in oncology, offering precision in tumor ablation, embolization, and delivering localized therapies. At radiology and oncology conferences, the convergence of cutting-edge techniques, like chemoembolization and radiofrequency ablation, with image-guidance is a central focus, revolutionizing cancer management, reducing side effects, and improving patient quality of life.

In oncology, the accurate staging of cancer is pivotal for determining treatment strategies and prognosis. Recent innovations in cancer staging have significantly advanced the role of medical imaging, providing insights into tumor extent and spread. At radiology and oncology conferences, these developments in computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET-CT) are at the forefront, enhancing the precision of cancer staging and guiding treatment decisions for improved patient care.

  • Enhanced Image Resolution
  • Fusion Imaging Technologies
  • Artificial Intelligence in Staging
  • Non-Invasive Lymph Node Evaluation
  • Molecular Imaging in Staging

Pediatric oncology imaging focuses on the use of medical imaging techniques to diagnose and monitor cancer in children. Recent innovations in this field have led to improved technologies like low-dose radiation CT scans, pediatric-specific MRI protocols, and advanced ultrasound techniques. These innovations, driven by the unique healthcare needs of children, have reduced radiation exposure and enhanced diagnostic accuracy, making pediatric oncology imaging a vital component in the early detection and treatment of cancer in young patients.

  • Low-Dose Radiation CT Scans
  • Pediatric-Specific MRI Protocols
  • Advanced Ultrasound Techniques
  • Minimizing Radiation Exposure
  • Child-Centric Imaging Innovations

Radiation safety and dose reduction are critical aspects of medical imaging. Recent innovations in this field have led to advanced technologies such as iterative reconstruction algorithms, dose-tracking software, and optimized CT protocols. These innovations prioritize patient safety by minimizing radiation exposure while maintaining image quality, making medical imaging safer and more efficient. At the forefront of radiology and healthcare discussions, these advancements are reshaping the landscape of diagnostic radiology, promoting patient well-being, and reducing potential risks.

Radiation oncology quality assurance is a critical component of cancer treatment, focusing on maintaining precise and safe radiation therapy delivery. Recent innovations include the integration of artificial intelligence for treatment planning and delivery verification, real-time tracking and monitoring of patient positioning, and advanced dosimetry techniques. These advances enhance the accuracy, safety, and efficiency of radiation therapy, ensuring patients receive the highest quality of care. At the forefront of radiation oncology discussions, these innovations underscore the commitment to delivering superior treatment outcomes with minimal side effects.

Cancer imaging in resource-limited settings addresses the unique challenges of diagnosing and managing cancer in regions with limited healthcare infrastructure. Recent innovations in this field include portable imaging devicestelemedicine solutions, and low-cost screening techniques. These innovations aim to bridge the gap in cancer care, ensuring early detection and treatment, even in resource-constrained environments. At the heart of discussions in radiology and oncology, these advancements represent a crucial step toward making cancer care accessible to all, regardless of setting or resources.

Imaging for treatment response assessment plays a crucial role in cancer management by evaluating the impact of therapeutic interventions. Recent innovations include functional imaging techniques like diffusion-weighted MRI and dynamic contrast-enhanced CT, which provide real-time insights into treatment efficacy. These advancements help clinicians make informed decisions, tailor therapies, and adjust treatment plans, ultimately improving patient outcomes. As a key focus in oncology and radiology, these innovations are transforming the way we monitor and adapt cancer treatments for better results.

The correlation between medical imaging and biomarkers in healthcare signifies a pivotal union of diagnostic techniques, allowing for a comprehensive understanding of diseases and treatment responses. Recent innovations have led to cutting-edge technologies such as radiogenomics, merging genetic data with imaging findings, and AI-powered image analysis for biomarker identification. At the forefront of healthcare discussions, these innovations enhance diagnostic accuracy, enabling precise and tailored therapies for improved patient care and outcomes.

  • Contrast Agents
  • Tracers
  • Proteins and Antibodies
  • Genomic Biomarkers
  • Tumor Markers
  • Functional Biomarkers
  • Inflammatory Markers

Imaging plays a pivotal role in the era of immunotherapy, where the body's immune system is harnessed to combat cancer and other diseases. Recent innovations have given rise to cutting-edge techniques like immune-related response criteria, allowing precise monitoring of immunotherapy efficacy. Radiomics, paired with artificial intelligence, extracts invaluable data from medical images, enhancing our ability to assess treatment responses and tailor immunotherapy for individual patients, fostering a new frontier in precision medicine and improved patient outcomes.

  • Checkpoint Inhibitors
  • Monoclonal Antibodies
  • CAR-T Cell Therapy
  • Cytokines
  • Cancer Vaccines
  • Oncolytic Viruses
  • Adoptive Cell Transfer
  • Immune Checkpoint Inhibitor Combinations
  • Bispecific Antibodies
  • Immune System Modulators

Radiomics is a burgeoning field that transforms medical imaging data into valuable information for patient diagnosis, prognosis, and treatment. Recent innovations, such as machine learning and artificial intelligence, extract intricate features from medical images, providing insights into disease characteristics, therapeutic responses, and even predicting patient outcomes. At the forefront of radiology, these developments are redefining healthcare, ushering in an era of precision medicine, where images hold the key to more accurate diagnoses and tailored treatments, ultimately improving patient care and outcomes.

Cancer epidemiology and prevention are vital in understanding the dynamics of cancer occurrence and curbing its impact. Recent innovations in this field encompass the study of genetic susceptibility, environmental factors, and lifestyle choices contributing to cancer risk. Cutting-edge research leverages genomic insights, precision prevention strategies, and advancements in early detection, offering the potential to reduce the global cancer burden. At the forefront of healthcare discussions, these innovations hold the promise of healthier futures and better cancer outcomes for individuals and populations alike.

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Skin Cancer
  • Stomach (Gastric) Cancer
  • Liver Cancer
  • Cervical Cancer
  • Thyroid Cancer
  • Bladder Cancer
  • Non-Hodgkin Lymphoma
  • Leukemia

Metastatic cancer, also known as stage IV cancer, is a type of cancer that has spread from its original site to other parts of the body. This occurs when cancer cells break away from the primary tumor and travel through the bloodstream or lymphatic system to form new tumors in different organs or tissues. Metastatic cancer is more challenging to treat than localized or early-stage cancer because it has already spread beyond the initial site, making it harder to remove or target with standard treatments like surgery or radiation therapy. Management of metastatic cancer often involves a combination of therapies, including chemotherapy, targeted therapies, immunotherapy, and palliative care, with the goal of extending life and improving the patient's quality of life.

Cancer immunology delves into the intricate relationship between the immune system and cancer, while the tumor microenvironment examines the surroundings where cancer cells flourish. Recent innovations in these fields have unveiled novel immunotherapies that empower the immune system to combat cancer. Researchers explore the dynamic interplay between immune cells, stromal cells, and cancer cells within the tumor microenvironment, leading to more effective therapies. These developments are reshaping cancer treatment, holding the promise of improved patient outcomes and a deeper understanding of immune responses to cancer.